Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States.
Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, and out-of-pocket (OOP) cost, among other …
Optimizing endometriosis diagnosis and mapping: The important role of advanced transvaginal ultrasound.
Endometriosis is estimated to affect 5%-10% of women of reproductive age, making timely diagnosis essential for initiating treatment, alleviating symptoms, and reducing the risk of disease progression. Unfortunately, the diagnostic …